-
Je něco špatně v tomto záznamu ?
Impact of tacrine and 7-methoxytacrine on gastric myoelectrical activity assessed using electrogastrography in experimental pigs
J. Bureš, D. Jun, M. Hrabinová, I. Tachecí, J. Květina, M. Pavlík, S. Rejchrt, T. Douda, M. Kuneš, K. Kuča, M. Kopáčová,
Jazyk angličtina Země Švédsko
Typ dokumentu časopisecké články, práce podpořená grantem
Grantová podpora
NT14270
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Článek
Zdroj
NLK
ROAD: Directory of Open Access Scholarly Resources
od 2012
PubMed
26757120
Knihovny.cz E-zdroje
- MeSH
- cholinesterasové inhibitory farmakologie MeSH
- elektromyografie MeSH
- hladké svalstvo účinky léků MeSH
- Sus scrofa MeSH
- takrin analogy a deriváty farmakologie MeSH
- žaludek účinky léků MeSH
- zvířata MeSH
- Check Tag
- ženské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
OBJECTIVES: Tacrine was the first acetylcholinesterase inhibitor approved for therapy of Alzheimer's disease. It has currently been withdrawn in some countries mostly due to the risk of hepatotoxicity and might be replaced by its derivate 7-methoxytacrine (7-MEOTA). The aim of this study was to assess the impact of these two compounds on gastric myoelectrical activity by means of surface cutaneous electrogastrography (EGG). METHODS: Twelve pigs (Sus scrofa f. domestica, weighing 30-35 kg) entered the study. A single dose of tacrine (200 mg i.m., n=6) or 7-MEOTA (200 mg i.m., n=6) was administrated. All EGG recordings were performed under general anaesthesia in the morning after 24 hours of fasting. Basal (30 minutes) and study recordings (150 minutes) were accomplished using an EGG stand (MMS, Enschede, the Netherlands). Results were expressed as dominant frequency of gastric slow waves, power analysis (areas of amplitudes) and power ratio assessment (ratio of the areas of amplitudes after and before study drug administration). RESULTS: Tacrine decreased EGG dominant frequency 10 minutes after its administration (from basal 3.1±0.6 to 2.8±0.6 cycles per minute; p=0.014). Tacrine induced a non-significant 60-minute increase of the power (with maximal value 493±533 μV2 at 20 minutes) and power ratio (with maximal value 2.04±3.4 at 10 minutes). Tacrine caused substantial gastric arrhythmia. 7-MEOTA did not influence dominant frequency of gastric slow waves significantly. 7-MEOTA caused a short-term late increase of the power ratio at 60 minutes (6.3±11.2; p=0.003). Blood cholinesterase activity did not correlate with any EGG parameter either after tacrine or 7-MEOTA at any time. CONCLUSIONS: Tacrine and 7-MEOTA have different impacts on EGG. Tacrine decreased dominant frequency and induced long-lasting gastric arrhythmia. 7-MEOTA caused a short-term late increase of the EGG power in experimental pigs.
- 000
- 00000naa a2200000 a 4500
- 001
- bmc16020028
- 003
- CZ-PrNML
- 005
- 20191118144453.0
- 007
- ta
- 008
- 160722s2015 sw f 000 0|eng||
- 009
- AR
- 035 __
- $a (PubMed)26757120
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sw
- 100 1_
- $a Bureš, Jan, $u 2nd Department of Medicine - Gastroenterology, Charles University in Prague, Faculty of Medicine in Hradec Králové, University Teaching Hospital, Hradec Kralove, Czech Republic. $d 1954- $7 nlk19990073060
- 245 10
- $a Impact of tacrine and 7-methoxytacrine on gastric myoelectrical activity assessed using electrogastrography in experimental pigs / $c J. Bureš, D. Jun, M. Hrabinová, I. Tachecí, J. Květina, M. Pavlík, S. Rejchrt, T. Douda, M. Kuneš, K. Kuča, M. Kopáčová,
- 520 9_
- $a OBJECTIVES: Tacrine was the first acetylcholinesterase inhibitor approved for therapy of Alzheimer's disease. It has currently been withdrawn in some countries mostly due to the risk of hepatotoxicity and might be replaced by its derivate 7-methoxytacrine (7-MEOTA). The aim of this study was to assess the impact of these two compounds on gastric myoelectrical activity by means of surface cutaneous electrogastrography (EGG). METHODS: Twelve pigs (Sus scrofa f. domestica, weighing 30-35 kg) entered the study. A single dose of tacrine (200 mg i.m., n=6) or 7-MEOTA (200 mg i.m., n=6) was administrated. All EGG recordings were performed under general anaesthesia in the morning after 24 hours of fasting. Basal (30 minutes) and study recordings (150 minutes) were accomplished using an EGG stand (MMS, Enschede, the Netherlands). Results were expressed as dominant frequency of gastric slow waves, power analysis (areas of amplitudes) and power ratio assessment (ratio of the areas of amplitudes after and before study drug administration). RESULTS: Tacrine decreased EGG dominant frequency 10 minutes after its administration (from basal 3.1±0.6 to 2.8±0.6 cycles per minute; p=0.014). Tacrine induced a non-significant 60-minute increase of the power (with maximal value 493±533 μV2 at 20 minutes) and power ratio (with maximal value 2.04±3.4 at 10 minutes). Tacrine caused substantial gastric arrhythmia. 7-MEOTA did not influence dominant frequency of gastric slow waves significantly. 7-MEOTA caused a short-term late increase of the power ratio at 60 minutes (6.3±11.2; p=0.003). Blood cholinesterase activity did not correlate with any EGG parameter either after tacrine or 7-MEOTA at any time. CONCLUSIONS: Tacrine and 7-MEOTA have different impacts on EGG. Tacrine decreased dominant frequency and induced long-lasting gastric arrhythmia. 7-MEOTA caused a short-term late increase of the EGG power in experimental pigs.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a cholinesterasové inhibitory $x farmakologie $7 D002800
- 650 _2
- $a elektromyografie $7 D004576
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a hladké svalstvo $x účinky léků $7 D009130
- 650 _2
- $a žaludek $x účinky léků $7 D013270
- 650 _2
- $a Sus scrofa $7 D034421
- 650 _2
- $a takrin $x analogy a deriváty $x farmakologie $7 D013619
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Jun, Daniel, $u Department of Toxicology and Military Pharmacy, Faculty of Military Health Sciences, University of Defence, Hradec Králové, Czech Republic. $d 1976- $7 xx0040498
- 700 1_
- $a Hrabinová, Martina $u Department of Toxicology and Military Pharmacy, Faculty of Military Health Sciences, University of Defence, Hradec Králové, Czech Republic. $7 xx0118798
- 700 1_
- $a Tachecí, Ilja $u 2nd Department of Medicine - Gastroenterology, Charles University in Prague, Faculty of Medicine in Hradec Králové, University Teaching Hospital, Hradec Kralove, Czech Republic. $7 xx0077741
- 700 1_
- $a Květina, Jaroslav, $u 2nd Department of Medicine - Gastroenterology, Charles University in Prague, Faculty of Medicine in Hradec Králové, University Teaching Hospital, Hradec Kralove, Czech Republic. $d 1930- $7 jk01071205
- 700 1_
- $a Pavlík, Michal $u Department of Toxicology and Military Pharmacy, Faculty of Military Health Sciences, University of Defence, Hradec Králové, Czech Republic. $7 _AN085450
- 700 1_
- $a Rejchrt, Stanislav, $u 2nd Department of Medicine - Gastroenterology, Charles University in Prague, Faculty of Medicine in Hradec Králové, University Teaching Hospital, Hradec Kralove, Czech Republic. $d 1963- $7 mzk2005306779
- 700 1_
- $a Douda, Tomáš, $u 2nd Department of Medicine - Gastroenterology, Charles University in Prague, Faculty of Medicine in Hradec Králové, University Teaching Hospital, Hradec Kralove, Czech Republic. $d 1970- $7 xx0075783
- 700 1_
- $a Kuneš, Martin $u Biomedical Research Centre, University Hospital, Hradec Králové, Slovakia. $7 xx0081968
- 700 1_
- $a Kuča, Kamil, $u Department of Toxicology and Military Pharmacy, Faculty of Military Health Sciences, University of Defence, Hradec Králové, Czech Republic. $d 1978- $7 xx0041831
- 700 1_
- $a Kopáčová, Marcela, $u 2nd Department of Medicine - Gastroenterology, Charles University in Prague, Faculty of Medicine in Hradec Králové, University Teaching Hospital, Hradec Kralove, Czech Republic. $d 1959- $7 xx0032944
- 773 0_
- $w MED00168352 $t Neuro endocrinology letters $x 0172-780X $g Roč. 36 Suppl 1, č. - (2015), s. 150-155
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/26757120 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20160722 $b ABA008
- 991 __
- $a 20191118144734 $b ABA008
- 999 __
- $a ok $b bmc $g 1154698 $s 944556
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2015 $b 36 Suppl 1 $c - $d 150-155 $i 0172-780X $m Neuro-endocrinology letters $n Neuro-endocrinol. lett. $x MED00168352
- GRA __
- $a NT14270 $p MZ0
- LZP __
- $a Pubmed-20160722